Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine for treating gout

A drug and gout technology, applied in the field of gout drugs, can solve the problems of unsatisfactory treatment effect, unsatisfactory indicators, large side effects, etc., and achieve the effect of no toxic side effects, good effect and short course of treatment

Inactive Publication Date: 2018-04-20
广西壮要方医院有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The medicines for the treatment of gout in the market are mainly western medicines. These western medicines have the disadvantages of high price and large side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] A medicine for treating gout, the weight ratio of each raw material is: 30 parts of cypress, 20 parts of kidney tea, 35 parts of knotweed, 20 parts of gourd tea, 30 parts of coix seed, 20 parts of Eclipta, 60 parts of a little red, 25 parts of chicken vine, 15 parts of star anise, 35 parts of berry, 15 parts of pine leaves, 25 parts of maple bark, 15 parts of diamond thorn, 30 parts of passepartout, 10 parts of water field seven, 15 parts of Polygonum multiflorum, 10 parts of blue skyflower 20 parts of kombu.

experiment example

[0011] In order to further prove the clinical curative effect of the medicine of the present invention, select 50 routine patients, carry out clinical observation to the curative effect of the medicine of the present invention.

[0012] Treatment method, pulverize and mix evenly with the prescription of embodiment 1 of the present invention, take 5g each time, every day 3 times.

[0013] Judgment of curative effect is mainly based on the disappearance of symptoms, and with reference to changes in the effect, it is divided into markedly effective, effective and ineffective.

[0014] Significantly effective: the symptoms are significantly relieved and the effect is significantly improved.

[0015] Effective: Symptoms and effects have been improved to a certain extent.

[0016] Ineffective: Symptoms and signs are not improved or the effect is not obvious.

[0017] Among the 50 cases of gout treated with the drug of the present invention, there were 22 males and 28 females. The...

example 1

[0019] Case 1 Su Moumou, male, 38 years old, toes, ankle joints, knee joints were red and swollen, hot pain, and knee joints were inconvenient. After one month of treatment with the medicine prepared in Example 1, the symptoms were relieved, and healed after two months. Follow up a case by regular visits to for two years without recurrence.

[0020] Case 2, Liang so-and-so, female, 44 years old, wrist joint, elbow joint red and swollen, hot pain, elbow joint activity inconvenience, after using the medicine treatment that embodiment 1 makes for one month, symptom alleviates, cures after two months, wrist joint The joints and elbow joints were free to move, and there was no recurrence in the follow-up for two years.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating gout. The medicine comprises the following raw materials by weight ratio: selaginella, folium orthosiphoni, gentrin knotweed, desmodium triquetrum, coixseeds, yerbadetajo herb, emilia sonchifolia, Chinese febervine herb, dysosma pleiantha, Rubus parvifolius, pine needle, heteropanax fragrans bark, chinaroot greenbier rhizome, Fructus Liquidambaris,lobedfruit schizocapsarhizome, fleece-flower root, nervilia fordii, and laminaria japonica. The medicine for treating gout selects 18 natural traditional Chinese medicines for compatibility, bulk drugs are subjected to synergism and have the effects for nourishing liver and kidney, clearing heat and detoxifying, and inducing dieresis, the medicine has inhibition effect for virus and bacteria, hasgood effect for treating gout, and has no toxic and side effect.

Description

technical field [0001] The invention relates to a medicine for treating gout and belongs to the technical field of traditional Chinese medicines. Background technique [0002] Gout is a disease caused by long-term purine metabolic disorders. Clinically, it is characterized by increased serum uric acid, joint redness, swelling, pain, recurrent attacks, joint deformities, and tophi formation. Seriously, long-term recurrent attacks will cause fibrosis of joint tissue and deposition of tophi in articular cartilage, synovium, and ligaments, which will gradually destroy and deform the diseased joints, lose motor function, and even be accompanied by various complications. Negative consequences such as renal failure. The state of an illness often shows effect repeatedly, does not heal for a long time, and treatment has certain difficulty. With the improvement of quality of life, the number and incidence of gout patients are gradually increasing. The medicines for the treatment of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8994A61K36/90A61P19/06
CPCA61K36/03A61K36/11A61K36/15A61K36/185A61K36/25A61K36/28A61K36/29A61K36/48A61K36/53A61K36/704A61K36/73A61K36/74A61K36/8945A61K36/896A61K36/898A61K36/8994A61K36/90A61K2300/00
Inventor 蒋群哲蒋伟哲蒋敏捷向雪香卢丽宁李素琼
Owner 广西壮要方医院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products